CHICAGO --- vaccine preventing cervical
cancer or cervical introduced to the United States in 2006, proven to reduce transmission by using "Papillomavirus"
or HPV, the
virus that causes genital disease cervical
cancer in more
than half of girls and young women, officers
U.S. health reported
Wednesday.
The result is much better than expected and allegedly also make those who are not vaccinated come off because the disease transmission cycle has been reduced, says a team of researchers in the Journal of Infectious Diseases.
"This report shows that HPV works well and this report should be used to arouse the importance of protection for young people to increase HPV vaccination," said Dr.. Thomas Frieden, director of the Centers for Disease Control and Prevention.
Frieden said that only one-third of girls in the U.S. between the ages of 13-17 years who have received full vaccination with HPV vaccine. The number was low when compared with vaccine delivery much more that is 80 per cent for young women in Rwanda.
"Low vaccination rate reflected in our 50,000 preventable disaster - 50 thousand of our current girls who someday might get cervical cancer in their lifetime - can be prevented if the vaccination rate could reach 80 percent," said Frieden.
In the study, a team led by Dr.Lauri Morkowitz using health survey data and compare it with the rate of transmission of the disease with HPV strain among teenage girls and young women aged 14-19 years in the four-year period before and after the vaccine is allowed for.
The result is much better than expected and allegedly also make those who are not vaccinated come off because the disease transmission cycle has been reduced, says a team of researchers in the Journal of Infectious Diseases.
"This report shows that HPV works well and this report should be used to arouse the importance of protection for young people to increase HPV vaccination," said Dr.. Thomas Frieden, director of the Centers for Disease Control and Prevention.
Frieden said that only one-third of girls in the U.S. between the ages of 13-17 years who have received full vaccination with HPV vaccine. The number was low when compared with vaccine delivery much more that is 80 per cent for young women in Rwanda.
"Low vaccination rate reflected in our 50,000 preventable disaster - 50 thousand of our current girls who someday might get cervical cancer in their lifetime - can be prevented if the vaccination rate could reach 80 percent," said Frieden.
In the study, a team led by Dr.Lauri Morkowitz using health survey data and compare it with the rate of transmission of the disease with HPV strain among teenage girls and young women aged 14-19 years in the four-year period before and after the vaccine is allowed for.
Tidak ada komentar:
Posting Komentar